BDSI Related Press Releases
-
BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of First Quarter 2013 Financials
-
BioDelivery Sciences to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
-
BioDelivery Sciences Appoints Thomas W. D'Alonzo to Board of Directors
-
BioDelivery Sciences Expands Product Pipeline with Acquisition of Patented Topical Clonidine Gel for the Treatment of Painful Diabetic Neuropathy
Back to BDSI Stock Lookup
